Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Eur J Endocrinol ; 134(4): 431-6, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8640293

ABSTRACT

We evaluated gonadal function in 63 patients with testicular cancer both within 1 month of unilateral orchiectomy before further treatment (pretreatment) and 3 years after treatment discontinuation (post-treatment). Sixteen patients underwent orchiectomy alone (group 1), nine patients underwent infradiaphragmatic radiotherapy (group 2) and 28 patients received four cycles (group 3) and 10 patients received six cycles (group 4) of cisplatin-based chemotherapy (cisplatin, vinblastine and bleomycin-PVB, or cisplatin, etoposide and bleomycin-PEB). Pretreatment semen analyses showed reduced sperm cell density, motility and impaired morphology of spermatozoa in all four groups (p > 0.05). At the same time elevated estradiol and decreased serum follicle-stimulating hormone (FSH) levels in 28.5% of subjects were correlated with high serum beta human chorionic gonadotropin concentrations. Semen analyses revealed the lowest values for all parameters after infradiaphragmatic radiotherapy. Sperm cell count, motility and morphology were significantly better in patients treated with orchiectomy alone or with a conventional dose of chemotherapy than in the groups that received radiotherapy or high doses of chemotherapy (p < 0.05). We also observed a correlation between serum FSH values and sperm cell density for both pretreatment and post-treatment in every group of patients (p < 0.05). Persistent subclinical Leydig cell dysfunction in groups treated with radiotherapy or high doses of chemotherapy was expressed by increased basal luteinizing hormone levels (78% of patients in group 2 vs 60% of patients in group 4) (p < 0.05) and by normal testosterone serum values (89% of patients in group 2 vs 80% of patients in group 4). Spermatogenesis and Leydig cell function are, therefore, persistently impaired in the majority of testicular cancer patients treated with radiotherapy or with more intensive chemotherapy.


Subject(s)
Germinoma/physiopathology , Germinoma/therapy , Testicular Neoplasms/physiopathology , Testicular Neoplasms/therapy , Testis/physiopathology , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chorionic Gonadotropin, beta Subunit, Human/blood , Cisplatin/administration & dosage , Combined Modality Therapy , Estradiol/blood , Follicle Stimulating Hormone/blood , Humans , Leydig Cells/physiology , Luteinizing Hormone/blood , Male , Middle Aged , Orchiectomy , Radiotherapy , Sperm Count , Sperm Motility , Spermatogenesis
2.
Am J Cardiol ; 67(9): 843-7, 1991 Apr 15.
Article in English | MEDLINE | ID: mdl-1707221

ABSTRACT

Glibenclamide, a hypoglycemic sulfonylurea, is a blocker of the adenosine triphosphatase-modulated potassium ion channels. The opening of these channels in the myocardial cells, induced by acute myocardial hypoxia, can be responsible for ischemic ventricular arrhythmias. To evaluate the antiarrhythmic effects of this drug 19 non-insulin-dependent diabetic patients were selected. They had coronary artery disease and evidence on Holter monitoring of ventricular premature complexes or nonsustained ventricular tachycardia, or both, induced by transient myocardial ischemia. In all patients, 24-hour electrocardiographic monitoring was performed to evaluate the number and duration of myocardial ischemic events, the frequency of ventricular premature complexes and nonsustained ventricular tachycardia per minute of ischemia and the percentage of ventricular premature complexes versus total ischemic beats. Selected patients were classified in 2 groups: group A (9 patients) received metformin (placebo) and group B (10 patients) was treated with glibenclamide. On the fourteenth day patients underwent 24-hour control monitoring. Then a crossover between the 2 groups was made and a new Holter monitoring sequence was performed at the end of the second phase. Results indicate that glibenclamide significantly (p less than 0.001) reduced both the frequency of ventricular premature complexes and the episodes of nonsustained ventricular tachycardia during transient myocardial ischemia, but did not change the number and duration of acute myocardial ischemic attacks and did not reduce the spontaneous ventricular arrhythmias. Thus, glibenclamide appears to have an antiarrhythmic effect in preventing ventricular arrhythmias induced by transient myocardial ischemia.


Subject(s)
Coronary Disease/physiopathology , Diabetes Mellitus, Type 2 , Glyburide/therapeutic use , Tachycardia/drug therapy , Adult , Angina Pectoris/physiopathology , Blood Glucose/analysis , Cardiac Complexes, Premature/physiopathology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Electrocardiography, Ambulatory , Heart Rate/drug effects , Heart Rate/physiology , Humans , Male , Metformin/therapeutic use , Middle Aged , Myocardial Infarction/physiopathology , Placebos , Time Factors , Ventricular Function/drug effects , Ventricular Function/physiology
3.
J Hypertens Suppl ; 6(1): S97-9, 1988 Nov.
Article in English | MEDLINE | ID: mdl-2851039

ABSTRACT

The aim of this study was to evaluate the usefulness of the angiotensin converting enzyme (ACE) inhibitor enalapril in a group of 30 patients (mean age 73.3 years) with moderate hypertension and normal haematological and chemical parameters (170 +/- 8.1 mmHg systolic and 104 +/- 5.8 mmHg diastolic blood pressure), who were receiving diuretic therapy with chlorthalidone (12.5 mg/day). This therapy caused a significant decrease in systolic and diastolic blood pressure (to 165 +/- 6.7 and 98 +/- 4.7 mmHg, respectively; P less than 0.001) but it also induced hypokalaemia (3.04 +/- 0.7 mmol/l; P less than 0.001) and multiple (greater than 10/h) and complex premature ventricular depolarizations (2nd, 3rd and 4th Lown grade). Enalapril treatment (5 mg/day for 5 days and 10 mg thereafter) was added to the diuretic therapy and after 2 months a further decrease in blood pressure was observed (to 158 +/- 5.6 mmHg systolic, P less than 0.001; 87.2 +/- 5.0 mmHg diastolic, P less than 0.001). Moreover, there was a significant reduction in the mean heart rate (from 79 to 72 beats/min, P less than 0.005) and an increase in serum potassium (to 4.19 +/- 0.2 mmol/l; P less than 0.001). In 80% of patients a 24-h dynamic electrocardiogram showed a significant reduction in both the number and complexity of premature ventricular depolarizations. Our findings suggest that ACE inhibitors can be useful in patients developing hypokalaemia during therapy. However, we are not yet able to explain the beneficial effects of enalapril in decreasing the frequency of premature ventricular depolarizations.


Subject(s)
Chlorthalidone/therapeutic use , Enalapril/therapeutic use , Hypertension/drug therapy , Aged , Aged, 80 and over , Blood Pressure/drug effects , Chlorthalidone/administration & dosage , Chlorthalidone/adverse effects , Clinical Trials as Topic , Drug Administration Schedule , Drug Therapy, Combination , Enalapril/administration & dosage , Female , Humans , Hypertension/blood , Hypertension/physiopathology , Male , Potassium/blood
5.
Acta Diabetol Lat ; 23(1): 57-61, 1986.
Article in English | MEDLINE | ID: mdl-3716750

ABSTRACT

The aim of the present study was to verify the validity of diagnostic criteria developed by the NDDG for the diagnosis of diabetes mellitus in old age. One hundred and fifty-one ambulatory old (range: 66-77 years) subjects (group A) underwent OGTT showing the following results: 33% normal, 12% non-diagnostic, 23% impaired glucose tolerance (IGT), 32% diabetic-type tolerance (DT). In addition, 84 subjects (group B) selected from 1978 to 1982 (42 aged 51-60 years, 30 aged 61-70, and 12 aged 71-80) with abnormalities of glucose tolerance during OGTT (IGT or DT) were asked to control their fasting plasma glucose every month during 1984. In group B a significant correlation between DT and subsequent development of fasting hyperglycemia was observed only in the subjects of the 6th and 7th decades of age. On the contrary, no subjects aged 71-80 years developed fasting hyperglycemia. The authors suggest that a high prevalence of abnormalities in glucose tolerance according to NDDG exists in old age which cannot be considered evidence of a true diabetes mellitus being unpredictive of a progression towards fasting hyperglycemia.


Subject(s)
Aging , Blood Glucose/metabolism , Diabetes Mellitus/diagnosis , Aged , Fasting , Glucose Tolerance Test , Humans , Hyperglycemia/etiology , Middle Aged
6.
Boll Soc Ital Biol Sper ; 61(2): 263-70, 1985 Feb 28.
Article in Italian | MEDLINE | ID: mdl-3994847

ABSTRACT

The increased and irregular post-maximal deflection of the two limbs of thromboelastographic traces has been variably interpreted by the Authors who utilize TEG as a global screening test for haemostasis evaluation. These thromboelastographic patterns have been attributed either to enhanced fibrinolytic activity or to raised clot's rectractility or even to incorrect technique. In our study, 1701 TEG's traces carried out in the last five years have been reviewed in order to evaluate the incidence of such patterns in both healthy subjects and in patients affected by different diseases. The data obtained show that such irregular post-maximal deflection's patterns are quite absence in healthy subjects while reaches a statistically significant incidence only in patients affected by diabetes mellitus, obesity or systemic hypertension. The results seem to suggest that the increased and irregular post-maximal TEG deflection is not a simply product of technique's mistake but may represent an useful index of some haemostatic alterations which need further studies.


Subject(s)
Blood Coagulation Disorders/diagnosis , Thrombelastography , Adult , Aged , Arteriosclerosis/complications , Biliary Tract Diseases/complications , Blood Coagulation Disorders/complications , Diabetes Complications , Female , Humans , Hypertension/complications , Joint Diseases/complications , Male , Middle Aged , Neoplasms/complications , Obesity/complications , Respiratory Tract Diseases/complications
9.
Arch Sci Med (Torino) ; 137(3): 443-7, 1980.
Article in Italian | MEDLINE | ID: mdl-7235932

ABSTRACT

The effects of salbutamol on the polygraphic pattern were studied in 10 patients with chronic obstructive lung disease. Salbutamol, administered by i.v. injection in a single dose of 100 gamma, caused an increase of heart rate, a decrease of PEP (by decrease in the TCI), a decrease of the Wessler's index and an increase of ejection fraction. These results suggest that salbutamol produces an improvement in cardiac function either by a direct inotropic action or by an afterload decrease.


Subject(s)
Albuterol , Lung Diseases, Obstructive/physiopathology , Myocardial Contraction/drug effects , Systole/drug effects , Adult , Cardiac Output/drug effects , Chronic Disease , Female , Heart Function Tests , Heart Rate/drug effects , Humans , Male , Middle Aged , Stimulation, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...